Navigation Links
GeneNews announces 2007 year end results
Date:3/26/2008

-------------------------------------------------------------------------

Commitments and contingencies

Shareholders' equity

Capital stock 44,290,930 44,234,409

Contributed surplus 2,733,562 2,255,390

Deficit (33,348,130) (23,714,085)

-------------------------------------------------------------------------

Total shareholders' equity 13,676,362 22,775,714

-------------------------------------------------------------------------

18,848,010 24,699,618

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Note: The full financial statements with notes and auditors' report are

found on SEDAR

GeneNews Limited

CONSOLIDATED STATEMENTS OF

OPERATIONS AND DEFICIT

(Expressed in Canadian dollars)

Years ended December 31

2007 2006

$ $

-------------------------------------------------------------------------

REVENUE

Milestone revenue 1,666,236 567,850

Upfront payment revenue 501,476 2,112,323

Fees for services - 603,095

-------------------------------------------------------------------------

2,167,712 3,283,268

-------------------------------------------------------------------------

EXPENSES

Research and development 8,902,433 9,518,
'/>"/>

SOURCE GeneNews Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. GeneNews CSO Dr. CC Liew awarded state honour by the Government of Malaysia
2. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
3. GeneNews initiates patient sample accrual for validation studies of colon cancer blood test
4. GeneNews receives ISO 13485 accreditation
5. GeneNews selected to present late-breaking abstract at AACR Annual Meeting
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email: